Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.01 (+6.25%)
At close: Oct 21, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Preferred Shares (2017)

Updated

Northwest Biotherapeutics (NWBO) reported Preferred Shares of $20.04 million for Q4 2017.

Analysis

Northwest Biotherapeutics (NWBO) Preferred Shares (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,169.76 Bn 1,138.35 Bn 19.71 Bn -
2 Johnson & Johnson 648.06 Bn 567.92 Bn 17.30 Bn -
3 AbbVie 503.37 Bn 476.48 Bn 12.70 Bn -
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn -
5 Novartis Ag 303.45 Bn 267.44 Bn 11.24 Bn -
6 Astrazeneca 269.03 Bn 242.72 Bn 12.86 Bn -
7 Amgen 242.08 Bn 197.48 Bn 7.24 Bn -
8 Gilead Sciences 194.88 Bn 169.07 Bn 6.22 Bn -
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn -
10 Northwest Biotherapeutics 249.81 Mn 239.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 20.04 Mn
API Access

Northwest Biotherapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=NWBO&period=max&api_key=YOUR_API_KEY